1 The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood Byron Butterworth, Ph.D. Butterworth Consulting John Chapman, Ph.D. ThermoGenesis.

Slides:



Advertisements
Similar presentations
Annual Dental Radiation Safety Briefing
Advertisements

Progress Against Lymphoma. 1970–1979 Progress Against Lymphoma 1970– : FDA approves doxorubicin, a vital part of combination chemotherapy.
THE CANCER/MITOSIS CONNECTION A cancer cell. All cells have a controlled rate of division that is appropriate for their role in the body. All cells have.
rhBMP-2: origin, biology and preclinical safety
Etiology Of Cancer &Carcinogenic Agents
Adult Stem Cells Stem Cells, Bone Marrow and Blood
Hematopoietic Stem Cells A hematopoietic stem cell is a cell isolated from the blood or bone marrow that can renew itself, can differentiate to a variety.
Acute Myelogenous Leukemia and its Impact on the Immune System
Hematopoietic Stem Cell Transplantation (HSCT) Overview Willis H Navarro, MD Medical Director, Transplant Services, NMDP Associate Clinical Professor,
Mesenchymal and Tissue-Specific Stem Cells ChemEng 590B: Tissue Engineering Lecture 4 January 31 st, 2013.
Cancer A class of non-infectious diseases occurring when cell cycle control mechanisms fail. Prefix: Onco.
Cancer.
Have tissue review sheets out and the animal tissue sheet.
Blood Cancer & Chromosome 21 By Manasi Shah. Core Binding Factor Acute Myeloid Leukemia (CBF-AML) AML is a type of cancer that affects bone marrow and.
Understanding Cancer Accelerated Biology. Faces of Cancer  You are a doctor interviewing a person (the piece of paper you got on the way in) with cancer.
National Committee for the Certification of Radiation Protection Officer BIOLOGICAL EFFECTS OF IONIZING RADIATION.
 Stem Cells. Understandings  Specialized tissues can develop by cell differentiation in multicellular organisms.  Differentiation involves the expression.
9 Radionuclide therapy.
1 Kepivance™ (Palifermin) Basis for Approval and Pediatric Studies Kepivance™ (Amgen) Approved 12/15/04 Joseph E. Gootenberg, M.D. Office of Oncology Drug.
Adaptive Response to Low Dose Radiation
 Stem Cells. Definition  The capacity of cells to divide and differentiate along different pathways is necessary in embryonic development. It also makes.
National Heart, Lung, and Blood Institute Cancer Research Opportunities Liana Harvath, NHLBI U.S. Department of Health and Human Services National Institutes.
CA-1 Preclinical Studies Philip Bentley, PhD Vice President Toxicology/Pathology Novartis Pharmaceuticals Corporation Philip Bentley, PhD Vice President.
Gene Expression Control of Gene Expression Activation of a gene that results in the formation of a _________. When transcription occurs a gene is “__________”
Brent Hoffman. HOXA9 is one of the HOX transcription factors regulating Anterior to Posterior patterning in early development.
Has someone been cured of HIV?. Some background on HIV O Causes AIDS O Mutates rapidly O Infects T cells of the immune system O Lysogenic (can hide inside.
Fig. 7.6 THE CELL CYCLE. CANCER Fig. 7.9 Cell Cycle Control  Cells that are not directed by the cell cycle control system tend to divide out of control.
Elizabeth Gorevski Kingsbrook Jewish Medical Center Brooklyn, NY.
STEM CELLS – ETHICAL ISSUES National 4 & 5 Biology – multicellular organisms.
Sterilization of Medical Devices: Bodhisatwa Das.
ROLE OF GENE EXPRESSION:  Activation of a gene that results in a protein  Cells DO NOT need to produce proteins for every code. GENOME:  Complete genetic.
Immunotherapy (Cancer therapy with T-Cells)
Leukemia Shannon Esmas Amanda Walzer English 100 ESP 2 November, 2015.
Stem cell concepts renew cancer research by John E. Dick Blood Volume 112(13): December 15, 2008 ©2008 by American Society of Hematology.
ASTM F748 Selecting Biological Test Methods
Stem Cells.
Neuroblastoma.
STEM CELLS.  Where do the different cells and tissues in your body come from?  Incredible as it seems, every cell was produced by mitosis from a small.
The Future of Chemical Toxicity Testing in the U.S.
 What is cancer?  What could happen in mitosis or meiosis that could cause cancer?  What environmental factors could cause cancer?
Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee July 15, 2003 Steven Hirschfeld, MD PhD CAPT USPHS Division of Oncology Drug.
1 1. What is Sterilization? 2. Type of Sterilization Methods. 3. What is ETO Sterilization? 4. Why & where ETO Sterilization used? 5. Fact about ETO.
BASIS OF CANCER CHEMOTHERAPY PHL 417 Dr. Mohamed M. Sayed-Ahmed.
Paige Myers & Mahek Shah.  Cancer is a disease in which the DNA of cells becomes damaged or changed and the affected cells do not respond to apoptosis.
Date of download: 6/22/2016 From: Acquired Aplastic Anemia Ann Intern Med. 2002;136(7): doi: / Venn diagram.
Leukemia By: Manuel Gomez. What is leukemia  Leukemia also called blood cancer  A disease in which the bone marrow and organs that form blood, produce.
CELL DIFFERENTIATION.
Stem Cells Untapped and unproven potential for treating human conditions Characteristics: capable of self renewal and differentiation Stem cell divides.
ASTM F748 Selecting Biological Test Methods
Induced Pluripotent Stem Cells
Stem Cell doubling is logarithmic
STEM CELLS AND CELLULAR DIFFERENTIATION
Cellular Differentiation
Pegfilgrastim Drugbank ID : DB00019
Leukemia Skeletal system
THE CANCER/MITOSIS CONNECTION
Neoplastic blood cells become pluripotent
Stem Trend By:Katelin & Haley
Bystander Effects.
CELL DIFFERENTIATION.
Adaptive Response to Low Dose Radiation
Stem Cells.
Stem Cells and Cellular Differentiation
with support from J.A. Swenberg & R. Budinsky
Early Use of Inhaled Ribavirin Can Improve Outcomes in High Risk Hematopoietic Stem Cell Transplant and Leukemia Patients with RSV Infection  Ron Mihelic,
Time to Insurance Approval in Private and Public Payers Does Not Influence Survival in Patients Who Undergo Hematopoietic Cell Transplantation  Vijaya.
Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation 
Monica L. Guzman, Craig T. Jordan  Cancer Cell 
Stem cell Basics.
Positive Genetox Findings on a Candidate Pharmaceutical…. Now What
Presentation transcript:

1 The Cancer Risk Associated with Ethylene Oxide in the Processing of Cord Blood Byron Butterworth, Ph.D. Butterworth Consulting John Chapman, Ph.D. ThermoGenesis Corp. March 30, 2007

2 Stem Cells in Cord Blood Are used to repopulate the bone marrow of chemotherapy patients – a process involving extensive cell division Are long lived, continuously dividing cells that create all hematopoietic progenitor cells for the lifetime of the patient Absolutely NO mutagenic changes are acceptable that could yield precancerous or cancerous cells

3 Ethylene Oxide (EtO) Proposed Sterilant for cord blood processing disposables FDA is proposing to allow 5 mg/disposable EtO is a potent direct-acting, DNA reactive mutagen and clastogen Produces lymphoma and/or leukemia in mice, rats and human beings Thus, these DNA cancer target sites are subject to mutagenic attack by EtO

4 Susceptibility Concerns Stem cells would be directly exposed to the DNA reactive mutagen EtO during processing –No anatomic barriers or detoxification mechanisms Proliferating cells are highly susceptible to mutation induction by DNA reactive agents L5178Y cells grown on plastic culture flasks sterilized with EtO result in mutation frequency increases of 6- to 14-fold

5 There is No “Safe” Dose of Ethylene Oxide Current FDA guidance would allow concentrations in the range of 30 to 100  g/ml of EtO in cord blood preparations No data are available that demonstrate the safety of these concentrations or any concentration of EtO for stem cell exposure FDA and EPA cancer risk models recognize no “safe” or “threshold” dose for direct acting mutagens

6 Only Gamma Irradiation or Steam should be allowed for Sterilization The cancer risk of ethylene oxide can be eliminated simply by the use of gamma irradiation or steam for the sterilization of all products for cord blood processing and storage Units of stored cord blood exposed to ethylene oxide should not be used without the transplant physician being made aware of the exposure New labeling for ethylene oxide exposed cord blood units should be considered